| ||
| UA labs testing patient tissue in move toward FDA approval The University of Alabama Crimson White This fall, The University of Alabama's Department of Biological Sciences will begin research to prove a treatment of chronic pain in patients with gastrointestinal disorders and fibromyalgia. Carol Duffy, an assistant professor in the department with a ... See all stories on this topic » | ||
| PARP inhibitors may be novel treatment strategy in women with HER2-positive ... News-Medical.net Poly (ADP-Ribose) polymerase (PARP) inhibitors, shown to have clinical activity when used alone in women with familial breast and ovarian cancers linked to BRCA mutations, may be a novel treatment strategy in women with HER2-positive breast cancers ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment